HDB Financial Services IPO Listing Live Updates: The much-awaited day has finally arrived as one of India’s largest non-bank lenders, and the biggest IPO of 2025 so far, HDB Financial Services, is set to make its stock market debut on…
The contract involves the construction of a 4/6 lane northern Ayodhya bypass with a total length of 35.40 km in Uttar Pradesh. Shares of Ceigall India Ltd ended at ₹271.45, up by ₹17.80, or 7.02%, on the BSE.
The company received a purchase order from African Rail Company for the supply and commissioning of two fully overhauled Cape Gauge ALCO diesel-electric locomotives. Shares of RITES Ltd ended at ₹279.20, down by ₹0.80, or 0.29%, on the BSE.
V-Mart Retail posted a 12.6% YoY revenue rise in Q1 FY25, reaching ₹885 Cr, supported by steady Same Store Sales Growth (SSSG) and 15 new store launches. The total store count now stands at 510 across India.
Crizac, a student recruitment solution provider, raised ₹258 crore from anchor investors ahead of its ₹860-crore IPO opening on July 2.
Stocks to Watch: Auto majors Hyundai and Maruti Suzuki logged a 6% YoY dip in June sales. Lupin gained momentum with US FDA approval for its eye gel. JSW Energy powered up with a battery deal. Godrej Properties exited Vivrut…
The notice pertains to discrepancies in input tax credit (ITC) reconciliation and suppression of outward tax liability based on differences between e-way bills and GST returns for the financial years 2018–19 to 2020–21, the company disclosed to exchanges.
Gross advances stood at ₹89,201 crore, reflecting an 8.02% year-on-year increase from ₹82,580 crore as of June 30, 2024. Shares of South Indian Bank Ltd ended at ₹31.57, up by ₹0.77, or 2.50%, on the BSE.
The move comes just three months after the company transitioned into a public entity. Shadowfax is likely to contribute an estimated ₹1,000–1,500 crore in fresh capital to the ₹4,000 crore pipeline of new-age companies tapping the primary markets.
Megasoft has announced the proposed sale of its entire 36.52% holding in Extrovis AG, Switzerland, to Refex Life Sciences for $15 million.